These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34775294)

  • 1. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies.
    De Pol M; Kolla NJ
    Psychiatry Res; 2021 Dec; 306():114256. PubMed ID: 34775294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
    Fyke W; Alarcon JM; Velinov M; Chadman KK
    Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower circulating endocannabinoid levels in children with autism spectrum disorder.
    Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J
    Mol Autism; 2019; 10():2. PubMed ID: 30728928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
    Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Hum Reprod Update; 2020 Jun; 26(4):586-602. PubMed ID: 32347309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder.
    Zou M; Liu Y; Xie S; Wang L; Li D; Li L; Wang F; Zhang Y; Xia W; Sun C; Wu L
    Open Biol; 2021 Feb; 11(2):200306. PubMed ID: 33529552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder.
    Fyke W; Premoli M; Echeverry Alzate V; López-Moreno JA; Lemaire-Mayo V; Crusio WE; Marsicano G; Wöhr M; Pietropaolo S
    Autism Res; 2021 Sep; 14(9):1854-1872. PubMed ID: 34173729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the endocannabinoid system in the rat valproic acid model of autism.
    Kerr DM; Downey L; Conboy M; Finn DP; Roche M
    Behav Brain Res; 2013 Jul; 249():124-32. PubMed ID: 23643692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.
    Schiavi S; Manduca A; Carbone E; Buzzelli V; Rava A; Feo A; Ascone F; Morena M; Campolongo P; Hill MN; Trezza V
    Neuropsychopharmacology; 2023 May; 48(6):897-907. PubMed ID: 36114286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma anandamide concentrations are lower in children with autism spectrum disorder.
    Karhson DS; Krasinska KM; Dallaire JA; Libove RA; Phillips JM; Chien AS; Garner JP; Hardan AY; Parker KJ
    Mol Autism; 2018; 9():18. PubMed ID: 29564080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
    Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
    Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.
    Zamberletti E; Gabaglio M; Parolaro D
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models.
    Pietropaolo S; Marsicano G
    Neurosci Biobehav Rev; 2022 Jan; 132():664-678. PubMed ID: 34813825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
    Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
    Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid system alterations in Alzheimer's disease: A systematic review of human studies.
    Berry AJ; Zubko O; Reeves SJ; Howard RJ
    Brain Res; 2020 Dec; 1749():147135. PubMed ID: 32980333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies.
    Pietropaolo S; Bellocchio L; Bouzón-Arnáiz I; Yee BK
    Prog Mol Biol Transl Sci; 2020; 173():183-208. PubMed ID: 32711810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.